HomeNews › New Security Label from Schreiner MediPharm Provides Tamper Evidence on Vials
Member news

New Security Label from Schreiner MediPharm Provides Tamper Evidence on Vials

Drug counterfeiters frequently fill original pharmaceutical containers with ineffective or harmful substitutes. In many cases, tampering with the containers cannot be detected. In the worst case, a falsified medicine may have fatal consequences for the patient to whom it has been administered. A tamper protection label with clear and irreversible first-opening indication that Schreiner MediPharm has developed specifically for vials can help prevent illegal reuse of original containers and protect their integrity.

The new security label wraps around the vial up to the level of the cap. To open the vial, a label-integrated tear strip has to be peeled off that cannot be resealed unnoticed. In addition, a warning message clearly indicating that the vial has been opened emerges. This first-opening indication can optionally be augmented by a void effect where previously invisible lettering or symbols separate from an indicator field.

For enhanced security, verification features for proof of authenticity may be incorporated into the label. Furthermore, special features are available such as a detachable documentation label, a transparent inspection window for checking the vial content, a light protection function for sensitive substances, or integrated NFC/RFID chips for digital applications.

Schreiner MediPharm’s new tamper-evident label is especially well-suited for small vials and custom-designed for the respective application. It can be processed in the normal labeling workflow in pharmaceutical production while preserving the product’s branding and design. Pharmaceutical manufacturers benefit from a solution that is precisely adapted to their requirements, easily fits their production processes, and helps protect their supply chain. For healthcare professionals, the label is not only easy to use but, above all, indicates at first glance whether the product is an originally sealed medication. As a result, patients can be protected against the potential administration of ineffective or harmful medications.